Revvity (RVTY) Stock Forecast, Price Target & Predictions


OverviewRevenueFinancialsChartTranscripts

RVTY Stock Forecast


Revvity (RVTY) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $111.57, with a high of $125.00 and a low of $95.00. This represents a -1.41% decline from the last price of $113.17.

$95 $102 $109 $116 $123 $130 High: $125 Avg: $111.57 Low: $95 Last Closed Price: $113.17

RVTY Stock Rating


Revvity stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (51.72%), 14 Hold (48.28%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 0 14 15 Strong Sell Sell Hold Buy Strong Buy

RVTY Price Target Upside V Benchmarks


TypeNameUpside
StockRevvity-1.41%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks8.42%

Price Target Trends


1M3M12M
# Anlaysts2519
Avg Price Target$120.00$116.40$113.47
Last Closing Price$113.17$113.17$113.17
Upside/Downside6.04%2.85%0.27%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-611--17
Jun, 26169--16
May, 26169--16
Apr, 26378--18
Mar, 26388--19
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 06, 2026Vijay KumarEvercore ISI$125.00$111.6611.95%10.45%
Jun 26, 2026Bernstein$115.00$113.531.29%1.62%
May 06, 2026Stifel Nicolaus$100.00$92.308.34%-11.64%
May 06, 2026Catherine Ramsey SchulteRobert W. Baird$117.00$92.3026.76%3.38%
May 04, 2026Robert W. Baird$125.00$86.6844.21%10.45%
Apr 14, 2026Luke SergottBarclays$95.00$92.642.55%-16.06%
Feb 03, 2026Catherine Ramsey SchulteRobert W. Baird$129.00$103.8924.17%13.99%
Feb 03, 2026Cowen & Co.$124.00$106.9715.92%9.57%
Feb 03, 2026Evercore ISI$118.00$107.0910.19%4.27%
Feb 03, 2026Barclays$118.00$107.0910.19%4.27%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jul 15, 2026Cowen & Co.BuyBuyhold
Jul 06, 2026Evercore ISIOutperformOutperformhold
Feb 03, 2026Cowen & Co.HoldHoldhold
Feb 03, 2026Cowen & Co.BuyBuyhold
Feb 03, 2026Evercore ISIOutperformOutperformhold
Feb 03, 2026BarclaysOverweightOverweighthold
Feb 02, 2026JefferiesHoldHoldhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Dec 15, 2025BarclaysOverweightOverweighthold
Dec 09, 2025Goldman SachsNeutralinitialise

Financial Forecast


EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.12$4.51$-0.95$2.41$2.08---
Avg Forecast$11.04$7.78$4.56$4.85$4.98$5.59$6.21$6.64
High Forecast$11.12$7.86$4.59$4.87$5.18$5.91$6.32$6.76
Low Forecast$10.90$7.63$4.54$4.79$4.87$4.91$6.12$6.54
Surprise %-26.45%-42.03%-120.83%-50.31%-58.23%---

Revenue Forecast

$3B $3B $4B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.83B$3.31B$2.75B$2.76B$2.86B---
Avg Forecast$4.98B$4.59B$2.73B$2.75B$2.86B$3.05B$3.23B$3.30B
High Forecast$5.00B$4.63B$2.74B$2.79B$2.89B$3.06B$3.25B$3.34B
Low Forecast$4.93B$4.52B$2.70B$2.74B$2.83B$3.04B$3.21B$3.26B
Surprise %-23.08%-27.83%0.68%0.04%-0.15%---

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$943.16M$569.18M$-118.38M$295.83M$241.68M---
Avg Forecast$1.38B$971.53M$569.72M$602.42M$627.36M$675.00M$776.55M$828.50M
High Forecast$1.39B$981.56M$572.85M$607.42M$646.75M$737.60M$789.41M$843.15M
Low Forecast$1.36B$952.74M$566.60M$597.43M$607.97M$612.39M$763.68M$815.67M
Surprise %-31.54%-41.41%-120.78%-50.89%-61.48%---

RVTY Forecast FAQ


Is Revvity stock a buy?

Revvity stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 14 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Revvity is a favorable investment for most analysts.

What is Revvity's price target?

Revvity's price target, set by 29 Wall Street analysts, averages $111.57 over the next 12 months. The price target range spans from $95 at the low end to $125 at the high end, suggesting a potential -1.41% change from the previous closing price of $113.17.

How does Revvity stock forecast compare to its benchmarks?

Revvity's stock forecast shows a -1.41% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (8.42%).

What is the breakdown of analyst ratings for Revvity over the past three months?

  • July 2026: 0% Strong Buy, 35.29% Buy, 64.71% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 6.25% Strong Buy, 37.50% Buy, 56.25% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 6.25% Strong Buy, 37.50% Buy, 56.25% Hold, 0% Sell, 0% Strong Sell.

What is Revvity’s EPS forecast?

Revvity's average annual EPS forecast for its fiscal year ending in December 2026 is $5.59, marking a 168.75% increase from the reported $2.08 in 2025. Estimates for the following years are $6.21 in 2027, and $6.64 in 2028.

What is Revvity’s revenue forecast?

Revvity's average annual revenue forecast for its fiscal year ending in December 2026 is $3.05B, reflecting a 6.91% increase from the reported $2.86B in 2025. The forecast for 2027 is $3.23B, and $3.3B for 2028.

What is Revvity’s net income forecast?

Revvity's net income forecast for the fiscal year ending in December 2026 stands at $675M, representing an 179.30% increase from the reported $241.68M in 2025. Projections indicate $776.55M in 2027, and $828.5M in 2028.